mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |